HOLON, Israel (AP) — HOLON, Israel (AP) — Compugen Ltd. (CGEN) on Tuesday reported a fourth-quarter loss of $6.1 million, after reporting a profit in the same period a year earlier.
The Holon, Israel-based company said it had a loss of 7 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 7 cents per share.
The drug developer posted revenue of $1.5 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $17.5 million.
For the year, the company reported that its loss narrowed to $14.2 million, or 16 cents per share. Revenue was reported as $27.9 million.
The company's shares closed at $1.81. A year ago, they were trading at $2.64.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.